Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future innovations in treating advanced prostate cancer.

Pratik Desai1, Juan A Jiménez, Chinghai Kao

  • 1Department of Urology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

The Urologic Clinics of North America
|April 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hidden diversity in the <i>Trichostomum brachydontium</i> complex (Pottiaceae, Bryophyta) revealed by integrative taxonomy.

Frontiers in plant science·2026
Same author

The effect of staging of fluidic oscillation on microbubble generation in viscous liquids.

The European physical journal. Special topics·2026
Same author

First-in-US Pilot Study of Aquablation in Ambulatory Surgery Centers: Clinical Outcomes and Economic Feasibility.

Urology·2025
Same author

The Burden of Revision Arthroplasty: An Ergonomic Analysis of Surgeon Posture in the Operating Room.

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews·2025
Same author

Integrative Taxonomy Reveals Hidden Diversity in the <i>Aloina catillum</i> Complex (Pottiaceae, Bryophyta).

Plants (Basel, Switzerland)·2024
Same author

Circumscription and Phylogenetic Position of Two Propagulose Species of <i>Syntrichia</i> (Pottiaceae, Bryophyta) Reveals Minor Realignments within the Tribe Syntricheae.

Plants (Basel, Switzerland)·2022
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Novel prostate cancer therapies are under investigation due to inadequate treatments for advanced stages. Experimental approaches like gene therapy may replace hormone ablation, offering better quality of life and disease control.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Prostate cancer is a prevalent disease with inadequate treatments for advanced stages.
  • Current therapies prolong survival but often lead to recurrence or disease progression.
  • Hormone ablation therapy, while common, has significant side effects and offers only temporary disease control.

Purpose of the Study:

  • To review novel therapeutic strategies for prostate cancer.
  • To discuss the potential of gene therapy, antiangiogenic therapy, and immune-based therapy.
  • To explore alternatives to current hormone ablation treatments for advanced prostate cancer.

Main Methods:

  • Review of current literature on prostate cancer treatment modalities.
  • Discussion of emerging experimental therapies including gene, antiangiogenic, and immune-based approaches.

Related Experiment Videos

  • Analysis of the molecular underpinnings of cancer to inform therapeutic development.

    • Main Results:

    • Novel therapeutic approaches are being developed targeting molecular events in cancer.
    • Gene therapy, antiangiogenic therapy, and immune-based therapy show promise.
    • These experimental modalities could potentially overcome limitations of current treatments.

    Conclusions:

    • Advanced prostate cancer requires innovative treatment strategies.
    • Gene therapy, antiangiogenic therapy, and immune-based therapy represent promising avenues.
    • These novel approaches may offer improved efficacy and quality of life compared to hormone ablation.